Results of Glucose-6-phosphate Dehydrogenase Deficiency Screening Relate with Cost of Phototherapy in Neonatal Hyperbilirubinemia; A Randomized Controlled Trial
Phase 4
Completed
- Conditions
- Glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency) is one of risk factors that should decrease the phototherapy threshold to be lower than G6PD-normal neonates.hyperbilirubinemia, phototherapy, G6PD deficiency, neonate, screening
- Registration Number
- TCTR20220705006
- Lead Sponsor
- /A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 241
Inclusion Criteria
1. Neonates born at 35 or more weeks' gestation, 2. Born in Burapha University Hospital
Exclusion Criteria
Born before before obtain inform consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cost of phototherapy 14 days after birth Hospital cost
- Secondary Outcome Measures
Name Time Method Incidence of G6PD deficiency 14 days after birth Cord blood G6PD screening